Table 1 Summary of the Clinical Data and Immunohistochemical Results for CD117 Expression in Small Cell Lung Carcinomas
From: Kit Expression in Small Cell Carcinomas of the Lung: Effects of Chemotherapy
Case | Age (years) | Sex | Stage | CD117-preCT (intensity/%) | First Line Chemotherapy | Clinical Response | CD117-PostCT (intensity/%) | Follow-Up (months) |
|---|---|---|---|---|---|---|---|---|
1 | 62 | M | LD | 3+/80% | Cis + Eto | PR | −/− | 14, DOD |
2 | 63 | F | ED | −/− | Carbo + Eto | NR | −/− | 6, DOD |
3 | 66 | M | LD | 3+/100% | Carbo + Eto | PR | 3+/80% | 11, DOD |
4 | 29 | F | ED | 3+/100% | Cis + Eto | CR | 1+/10% | 45, DOD |
5 | 75 | F | LD | 3+/80% | Carbo + Eto | CR | −/− | 42, DOD |
6 | 56 | F | LD | −/− | Cis + Eto | PR | −/− | 20, DOD |
7 | 61 | F | LD | 1+/10% | Carbo + Eto | CR | −/− | 55, DOD |
8 | 59 | M | ED | 2+/60% | Cis + Eto | PR | 1+/3% | 22, DOD |
9 | 65 | M | ED | 3+/70% | Cis + Eto | PR | 2+/80% | 30, DOD |
10 | 82 | M | ED | 3+/75% | Cis + Eto | CR | 1+/10% | 32, DOD |
11 | 73 | F | ED | 3+/100% | Cis + Eto | NR | 3+/70% | 10, DOD |
12 | 59 | M | ED | 3+/100% | Carbo + Eto | NR | 1+/15% | 19, DOD |
13 | 54 | F | LD | −/− | Cis + Eto | PR | −/− | 11, DOD |
14 | 73 | M | ED | 3+/100% | Carbo + Eto | PR | 3+/100% | 34, DOD |
15 | 74 | M | ED | 2+/90% | Cis + Eto | PR | −/− | 30, DOD |
16 | 71 | M | ED | 2+/80% | Carbo + Eto | NR | 1+/10% | 10, DOD |
17 | 71 | M | ED | 3+/100% | Cis + Eto | PR | 3+/90% | 20, DOD |
18 | 75 | M | ED | 3+/100% | Cis + Eto | PR | 3+/100% | 22, DOD |
19 | 63 | M | ED | 3+/100% | Cis + Eto | PR | 3+/80% | 19, DOD |
20 | 57 | M | ED | 3+/100% | Cis + Eto | PR | 3+/100% | 11, DOD |
21 | 65 | M | ED | 3+/100% | Cis + Eto | CR | 3+/100% | 33, DOD |
22 | 73 | M | LD | 3+/100% | Cis + Eto | CR | 2+/80% | 92, AWD |
23 | 73 | F | LD | 3+/80% | Cis + Eto | NR | 1+/2% | 8, DOD |
24 | 60 | F | LD | 3+/100% | Carbo + Eto | CR | 1+/3% | 23, AWD |
25 | 75 | F | LD | −/− | Carbo + Eto | CR | −/− | 46, AWD |
26 | 71 | M | ED | 3+/90% | Cis + Eto | PR | −/− | 11, DOD |
27 | 72 | M | ED | −/− | Cis + Eto | RC | −/− | 51, DOD |
